Active — Not RecruitingNot Applicable

Care Planning Framework in Advanced Cancer (ABC123)

United States70 participantsStarted 2022-02-15

Plain-language summary

Pilot study assessing the feasibility and acceptability of the ABC123 framework, as well as goal concordance between patient and clinician stated goals. Patients \>60 years old with recently diagnosed advanced, incurable cancer in for a first consultation at a participating medical oncology clinic. The team will pilot test the ABC123 framework delivery by an advanced practice provider working with a medical oncologist to inform the overall care planning process. This framework will routinely incorporate and implement existing resources from these 3 transdisciplinary tenets (geriatric, oncology, and palliative medicine) into initial care planning in a patient-centered manner. The team will follow patients from initial care planning to 6 months post-intervention and assess additional stakeholder feedback on barriers and facilitators to implementation.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Provision to sign and date the consent form
✓. Age \>65 years old, or \>60 with at least one deficit on a geriatric screen.
✓. Stated willingness to comply with all study procedures and be available for the duration of the study
✓. Diagnosis of a solid-tumor cancer that is not curable with surgery or radiation within the 6 mos. prior to consenting. And that would potentially be treated with systemic cytotoxic chemotherapy. If molecular marker status is pending for a particular tumor, patients may still be approached for enrollment in the study.
✓. New patient consultation within the UCHealth Denver Metro system or newly diagnosed with recurrent metastatic/incurable disease
✓. English speaking only for the pilot portion

Exclusion criteria

✕. Have a diagnosis of a different advanced cancer that has required systemic therapy
✕. Have any condition that, in the opinion of the investigator, would compromise the well-being of the subject or the study or prevent the subject from meeting or performing study requirements

What they're measuring

Feasibility measured through recruitment

Timeframe: 3 years

Feasibility measured through retention in sessions

Timeframe: baseline to visit 2

Feasibility measured through retention in follow up

Timeframe: baseline to 6 month follow up

Trial details

NCT IDNCT05408507

SponsorUniversity of Colorado, Denver

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Advanced Cancer trials